Drug shortage: Hydromorphone Hydrochloride Injection (DILAUDID, HYDROMORPHONE HYDROCHLORIDE)
FDA lists 26 presentations as Current. Availability: Unavailable (7), Limited Availability (3), Available (16). Reason: Other; Demand increase for the drug. Companies: Hikma Pharmaceuticals USA, Inc., Fresenius Kabi USA, LLC, Teva Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company.
- Published by source
- 2017-10-31
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-27
Affected
- Manufacturer
- Hikma Pharmaceuticals USA, Inc.
- Products
- Hydromorphone Hydrochloride Injection DILAUDID HYDROMORPHONE HYDROCHLORIDE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
- Next release October 2026. Check wholesalers for inventory.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2017-10-31
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #901 | new | 2026-10-22 | d4422fbb2813…70f8a9 | 6c4b1d2686b5…917576 |
| #1159 | update | 2026-10-23 | 38f1a51e5134…a5f880 | 18e454014e63…2bdde3 |
| #1356 | update | 2026-10-23 | a10df318ee28…83ed0e | 1d7f6c95eeea…5f79aa |
| #2199 | update | 2026-10-27 | 702bfc38bc08…50f866 | 470d46a661a6…8b7af0 |
Chain head: #2286 e212558e872c…954bc1